Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

Overview of attention for article published in Journal of Hematology & Oncology, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 1,220)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 32 news stories from 32 outlets.

The NANO Group has announced their trademark on INDOLE-A David Uhalley and Mike Robinson, the Nanobles Corporate Team Mike…

The NANO Group has announced their trademark on INDOLE-A David Uhalley and Mike Robinson, the Nanobles Corporate Team Mike…

The NANO Group has announced their trademark on INDOLE-A David Uhalley and Mike Robinson, the Nanobles Corporate Team Mike…

The NANO Group has announced their trademark on INDOLE-A David Uhalley and Mike Robinson, the Nanobles Corporate Team Mike…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 28 additional news stories.